US09062W2044
US09062W2044
BioLife Solutions, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 96.214.000 | 74.647.000 | 28.9% |
| Cost of Revenue | 34.096.000 | 24.551.000 | 38.9% |
| Gross Profit | 62.118.000 | 50.096.000 | 24.0% |
| 78.720.000 | 54.573.000 | 44.2% | |
| Operating Income | -16.602.000 | -4.477.000 | 270.8% |
| Pretax Income | -12.081.000 | -8.823.000 | 36.9% |
| Net Income Common Stockholders | -4.595.000 | -20.184.000 | 77.2% |
| -- | -- | -- | |
| -- | -- | -- |